Home › Companies › PRECISION BIOSCIENCES, INC. › 2024-2025
At PRECISION BIOSCIENCES, INC.'s shareholder meeting held May 28, 2025, in the 2024-2025 proxy season, 50 asset managers reported how they voted in their SEC Form N-PX filings, covering 226 separate fund positions. Their filings are grouped here into 6 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approval, on an advisory (non-binding) basis, of the compensation of our named executive… — FOR was 93% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: PRECISION BIOSCIENCES, INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 3, 2025.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and PRECISION BIOSCIENCES, INC.’s Form 8-K, filed June 3, 2025 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of May 28, 2025: 5 items on PRECISION BIOSCIENCES, INC.’s Form 8-K, filed June 3, 2025: 1 approved · 4 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2024-2025 2025-2026
Explore PRECISION BIOSCIENCES, INC. in the interactive database Compare manager voting policies
These tallies are PRECISION BIOSCIENCES, INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 3, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Kevin J. Buehler | 2,987,931 | -- | -- | 765,409 | 3,753,012 | 80% | Not verified | — |
| Elect Director: Shari Lisa Piré | 2,953,557 | -- | -- | 799,783 | 3,753,012 | 79% | Not verified | — |
| 2. Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025 | 7,445,447 | 12,604 | 48,301 | -- | 0 | 99.8% | Not verified | — |
| 3. Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers | 3,389,745 | 261,406 | 102,189 | -- | 3,753,012 | 93% | Not verified | — |
| 5. Approval of an amendment to the Company's Certificate of Incorporation to reflect changes in Delaware law regarding officer exculpation | 3,532,156 | 162,255 | 58,929 | -- | 3,753,012 | 96% | Approved | — |
Source: PRECISION BIOSCIENCES, INC., Form 8-K, filed with the SEC on June 3, 2025 — read the filing on EDGAR.
Each item below shows how the 50 asset managers that disclosed a PRECISION BIOSCIENCES, INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of PRECISION BIOSCIENCES, INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 2 wordings of this item as funds reported it.
80% Majority: yes · of votes cast
Description as filed by funds: Election of Class III Directors: Kevin J. Buehler
PRECISION BIOSCIENCES, INC.’s own tally for this item (“Elect Director: Kevin J. Buehler”): 2,987,931 for, 765,409 withheld, per its Form 8-K filed June 3, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 80% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 12 asset managers below reported 315,337 for, 44,294 withheld, 40,149 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 166,485 | 0 | 0 | 0 | For |
| Fidelity | 62,506 | 0 | 0 | 0 | For |
| Jacob Funds Inc. | 61,646 | 0 | 0 | 0 | For |
| RBC FUNDS TRUST | 0 | 0 | 40,000 | 0 | Abstain |
| Dimensional | 0 | 0 | 0 | 39,461 | Withhold |
| BlackRock | 14,319 | 0 | 0 | 0 | For |
| Northern Trust | 8,742 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 4,824 | Withhold |
| Equitable | 1,252 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 387 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 149 | 0 | Abstain |
| Guggenheim | 0 | 0 | 0 | 9 | Withhold |
Combines 2 wordings of this item as funds reported it.
79% Majority: yes · of votes cast
Description as filed by funds: Election of Class III Directors: Shari Lisa Pire
PRECISION BIOSCIENCES, INC.’s own tally for this item (“Elect Director: Shari Lisa Piré”): 2,953,557 for, 799,783 withheld, per its Form 8-K filed June 3, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 79% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 12 asset managers below reported 306,595 for, 53,036 withheld, 40,149 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 166,485 | 0 | 0 | 0 | For |
| Fidelity | 62,506 | 0 | 0 | 0 | For |
| Jacob Funds Inc. | 61,646 | 0 | 0 | 0 | For |
| RBC FUNDS TRUST | 0 | 0 | 40,000 | 0 | Abstain |
| Dimensional | 0 | 0 | 0 | 39,461 | Withhold |
| BlackRock | 14,319 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 0 | 0 | 8,742 | Withhold |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 4,824 | Withhold |
| Equitable | 1,252 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 387 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 149 | 0 | Abstain |
| Guggenheim | 0 | 0 | 0 | 9 | Withhold |
96% Approved · of votes cast
Description as filed by funds: Approval of an amendment to our Certificate of Incorporation to reflect changes in Delaware law regarding officer exculpation.
PRECISION BIOSCIENCES, INC.’s own tally for this item (“5. Approval of an amendment to the Company's Certificate of Incorporation to reflect changes in Delaware law regarding officer exculpation”): 3,532,156 for, 162,255 against — passed, per its Form 8-K filed June 3, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Item 5 – Approval of an amendment to the Company's Certificate of Incorporation to reflect changes in Delaware law regarding officer exculpation.”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 12 asset managers below reported 359,691 for, 40,089 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 166,485 | 0 | 0 | 0 | For |
| Fidelity | 62,506 | 0 | 0 | 0 | For |
| Jacob Funds Inc. | 21,557 | 40,089 | 0 | 0 | Mixed |
| RBC FUNDS TRUST | 40,000 | 0 | 0 | 0 | For |
| Dimensional | 39,461 | 0 | 0 | 0 | For |
| BlackRock | 14,319 | 0 | 0 | 0 | For |
| Northern Trust | 8,742 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 4,824 | 0 | 0 | 0 | For |
| Equitable | 1,252 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 387 | 0 | 0 | 0 | For |
| John Hancock | 149 | 0 | 0 | 0 | For |
| Guggenheim | 9 | 0 | 0 | 0 | For |
Combines 7 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Description as filed by funds: Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers (commonly referred to as the "say-on-pay vote").
PRECISION BIOSCIENCES, INC.’s own tally for this item (“3. Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers”): 3,389,745 for, 261,406 against, per its Form 8-K filed June 3, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 166,485 | 0 | 0 | 0 | For |
| Fidelity | 62,506 | 0 | 0 | 0 | For |
| Jacob Funds Inc. | 21,557 | 0 | 40,089 | 0 | Mixed |
| RBC FUNDS TRUST | 40,000 | 0 | 0 | 0 | For |
| Dimensional | 0 | 39,461 | 0 | 0 | Against |
| BlackRock | 14,319 | 0 | 0 | 0 | For |
| Northern Trust | 8,742 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 4,824 | 0 | 0 | Against |
| Equitable | 1,252 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 387 | 0 | 0 | 0 | For |
| John Hancock | 149 | 0 | 0 | 0 | For |
| Guggenheim | 9 | 0 | 0 | 0 | For |
Fund voting reports, all 12 managers: 315,406 for, 44,285 against, 40,089 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 766,051 | 0 | 0 | 0 | For |
| Bleichroeder LP | 213,072 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 64,487 | 0 | 0 | 0 | For |
| BALYASNY ASSET MANAGEMENT L.P. | 0 | 46,263 | 0 | 0 | Against |
| Moloney Securities Asset Management, LLC | 35,333 | 0 | 0 | 0 | For |
| BlackRock | 34,907 | 0 | 0 | 0 | For |
| Renaissance | 33,902 | 0 | 0 | 0 | For |
| Northern Trust | 21,340 | 0 | 0 | 0 | For |
| Vanguard | 13,590 | 0 | 0 | 0 | For |
| Two Sigma | 12,265 | 0 | 0 | 0 | For |
| Prudential/PGIM | 0 | 4,834 | 0 | 0 | Against |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 4,824 | 0 | 0 | Against |
| Vivo Capital, LLC | 4,675 | 0 | 0 | 0 | For |
| HAMILTON LANE ADVISORS LLC | 2,636 | 0 | 0 | 0 | For |
| STIFEL NICOLAUS & CO INC \MO\ | 1,927 | 0 | 0 | 0 | For |
| State Street | 1,742 | 0 | 0 | 0 | For |
| ENVESTNET ASSET MANAGEMENT INC | 0 | 1,487 | 0 | 0 | Against |
| CWM, LLC | 1,005 | 0 | 0 | 0 | For |
| CARY STREET PARTNERS FINANCIAL LLC | 1,000 | 0 | 0 | 0 | For |
| ROCKEFELLER FINANCIAL LLC | 1,000 | 0 | 0 | 0 | For |
| Texas Yale Capital Corp. | 333 | 0 | 0 | 0 | For |
| Fisher Asset Management, LLC | 300 | 0 | 0 | 0 | For |
| STEINBERG ASSET MANAGEMENT LLC | 183 | 0 | 0 | 0 | For |
| John Hancock | 157 | 0 | 0 | 0 | For |
| ArrowMark Colorado Holdings LLC | 0 | 148 | 0 | 0 | Against |
Institutional-manager reports, all 40 managers: 1,210,304 for, 57,753 against. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
100% Fund and manager reports combined; may count the same shares twice · no official result
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| Jacob Funds Inc. | 0 | 0 | 0 | 0 | -- |
| RBC FUNDS TRUST | 0 | 0 | 0 | 0 | -- |
| Dimensional | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 0 | 0 | -- |
| John Hancock | 0 | 0 | 0 | 0 | -- |
| Guggenheim | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 12 managers: 360,319 1 year, 39,461 3 year.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 0 | 0 | 0 | 0 | -- |
| Bleichroeder LP | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| BALYASNY ASSET MANAGEMENT L.P. | 0 | 0 | 0 | 0 | -- |
| Moloney Securities Asset Management, LLC | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Renaissance | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| Two Sigma | 0 | 0 | 0 | 0 | -- |
| Prudential/PGIM | 0 | 0 | 0 | 0 | -- |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| Vivo Capital, LLC | 0 | 0 | 0 | 0 | -- |
| HAMILTON LANE ADVISORS LLC | 0 | 0 | 0 | 0 | -- |
| STIFEL NICOLAUS & CO INC \MO\ | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| ENVESTNET ASSET MANAGEMENT INC | 0 | 0 | 0 | 0 | -- |
| CARY STREET PARTNERS FINANCIAL LLC | 1,000 | 0 | 0 | 0 | For |
| ROCKEFELLER FINANCIAL LLC | 0 | 0 | 0 | 0 | -- |
| Texas Yale Capital Corp. | 0 | 0 | 0 | 0 | -- |
| Fisher Asset Management, LLC | 0 | 0 | 0 | 0 | -- |
| STEINBERG ASSET MANAGEMENT LLC | 0 | 0 | 0 | 0 | -- |
| John Hancock | 0 | 0 | 0 | 0 | -- |
| ArrowMark Colorado Holdings LLC | 0 | 0 | 0 | 0 | -- |
| MELLON INVESTMENTS Corp | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 36 managers: 1,000 for, 1,265,893 1 year, 11 3 year. Showing the 25 largest; every one is in the interactive database (link above).
99.8% Majority: yes · of votes cast
Description as filed by funds: Ratification of the appointment of Deloitte & Touche LLP as Precision's independent registered public accounting firm for 2025.
PRECISION BIOSCIENCES, INC.’s own tally for this item (“2. Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2025”): 7,445,447 for, 12,604 against, per its Form 8-K filed June 3, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 12 asset managers below reported 399,780 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 166,485 | 0 | 0 | 0 | For |
| Fidelity | 62,506 | 0 | 0 | 0 | For |
| Jacob Funds Inc. | 61,646 | 0 | 0 | 0 | For |
| RBC FUNDS TRUST | 40,000 | 0 | 0 | 0 | For |
| Dimensional | 39,461 | 0 | 0 | 0 | For |
| BlackRock | 14,319 | 0 | 0 | 0 | For |
| Northern Trust | 8,742 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 4,824 | 0 | 0 | 0 | For |
| Equitable | 1,252 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 387 | 0 | 0 | 0 | For |
| John Hancock | 149 | 0 | 0 | 0 | For |
| Guggenheim | 9 | 0 | 0 | 0 | For |
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 11,088,234 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 1.50% |
| 2 | Fidelity | 0.56% |
| 3 | Jacob Funds Inc. | 0.56% |
| 4 | RBC FUNDS TRUST | 0.36% |
| 5 | Dimensional | 0.36% |
| 6 | BlackRock | 0.13% |
| 7 | Northern Trust | 0.08% |
| 8 | BRIDGEWAY FUNDS INC | 0.04% |
| 9 | Equitable | 0.01% |
| 10 | MASTER INVESTMENT PORTFOLIO | <0.01% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Lynx1 Capital Management LP | 6.91% |
| 2 | Bleichroeder LP | 1.92% |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 0.58% |
| 4 | BALYASNY ASSET MANAGEMENT L.P. | 0.42% |
| 5 | Moloney Securities Asset Management, LLC | 0.32% |
| 6 | BlackRock | 0.31% |
| 7 | Renaissance | 0.31% |
| 8 | Northern Trust | 0.19% |
| 9 | Vanguard | 0.12% |
| 10 | Two Sigma | 0.11% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Octagon Capital Advisors LP | — | 13G |
| Aberdeen Group plc | — | 13G |
| Empery Asset Management, LP | — | 13G |
| Bleichroeder LP | — | 13G |
| Readout Capital, LP | — | 13G |
| Lynx1 Capital Management LP | — | 13G |
| Aquilo Capital Management | — | DEF14A |
| Lynx1 Capital Advisors LLC | — | DEF14A |
| Tang Capital Management | — | DEF14A |
| Novartis Pharma AG | — | 13G |
Percentages above are of 11,088,234 shares outstanding, as reported by PRECISION BIOSCIENCES, INC. on its Form 10-Q dated May 8, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from PRECISION BIOSCIENCES, INC.’s 10-Q dated May 8, 2025. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
PRECISION BIOSCIENCES, INC. proxy season coverage: 2024-2025 (this page) · 2025-2026.
proxyvotesnow.com, “PRECISION BIOSCIENCES (DTIL) 2025 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/precision-biosciences-inc/2025 (version of November 9, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.